<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:dc="http://purl.org">
<channel>
<title>Daily Pharmaceuticals industry news in South Africa</title>
<link>https://www.bizcommunity.com/196/398.html</link>
<description>South Africa Pharmaceuticals news</description>
<ttl>15</ttl>
<category>Pharmaceuticals news - South Africa</category>
<image>
<url>https://www.bizcommunity.com/res/img/logo.gif</url>
<title>Daily Pharmaceuticals industry news in South Africa</title>
<link>https://www.bizcommunity.com/196/398.html</link>
</image>
<language>en-us</language>
<pubDate>Sun, 01 Nov 2026 20:44:34 +0200</pubDate>
<item>
	<title>Dis-Chem brings the World of Beauty to Cape Town</title>
	<link>https://www.bizcommunity.com/article/dis-chem-brings-the-world-of-beauty-to-cape-town-858663a</link>
	<description>Canal Walk’s centre court buzzed with excitement as Dis-Chem officially opened the third edition of its World of Beauty in Cape Town — which runs until 1 November 2026.</description>
	<media:content url="https://biz-file.com/c/2610/826649-1200x839.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/826649-1200x839.jpg?5" length="442858" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2610/826649.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272949</guid>
	<pubDate>Fri, 30 Oct 2026 16:43:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Dis-Chem’s Better Rewards programme supports 8% revenue growth</title>
	<link>https://www.bizcommunity.com/article/dis-chems-better-rewards-programme-supports-8-revenue-growth-414299a</link>
	<description>Dis-Chem reported an 8% increase in Group revenue to R23bn for the six months ended 31 August 2026, although earnings came under pressure, with basic earnings per share (EPS) down 13.3% to 64.1 cents and headline earnings per share (HEPS) declining 12.8% to 64.3 cents.</description>
	<media:content url="https://biz-file.com/c/2610/826578.png?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/826578.png?5" length="66452" type="image/png" />
	<media:thumbnail url="https://biz-file.com/c/2610/826578.png?5" width="240" height="135" />
	<guid isPermaLink="false">1-272985</guid>
	<pubDate>Fri, 30 Oct 2026 10:30:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Cipla wins court fight over HIV pill tender</title>
	<link>https://www.bizcommunity.com/article/cipla-wins-court-fight-over-hiv-pill-tender-525790a</link>
	<description>A court has set aside the awards for the daily HIV pill in a R15.5-billion antiretroviral tender.

Two winning bidders are excluded because the licence for the factory they relied on had expired before bidding closed.

The health department has 120 days to redo the awards, while current suppliers will keep delivering in the meantime.</description>
	<media:content url="https://biz-file.com/c/2610/826028.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/826028.jpg?5" length="47700" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2610/826028.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272806</guid>
	<pubDate>Fri, 23 Oct 2026 09:29:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Buying Ozempic on Instagram is a major red flag, warns Novo Nordisk</title>
	<link>https://www.bizcommunity.com/article/buying-ozempic-on-instagram-is-a-major-red-flag-warns-novo-nordisk-969334a</link>
	<description>Novo Nordisk’s vice president and general manager in South Africa, Sara Norcross, said that online spaces are increasingly blurring the line between visibility and legitimacy as social media influencers, online stores, and messaging apps sell illicit and unregulated weight-loss drugs. She recently participated in the Pharmaceutical Task Group (PTG) Media in Sandton.</description>
	<media:content url="https://biz-file.com/c/2610/825369-1200x800.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/825369-1200x800.jpg?5" length="194207" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2610/825369.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272604</guid>
	<pubDate>Fri, 16 Oct 2026 08:56:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Demand for cheaper Ozempic options prompts compounding rule review</title>
	<link>https://www.bizcommunity.com/article/demand-for-cheaper-ozempic-options-prompts-compounding-rule-review-292717a</link>
	<description>South Africa is revising its rules on customising medicines, including sought-after GLP-1 treatments for diabetes and weight loss, health regulators said, warning pharmacies not to act as small-scale manufacturers.</description>
	<media:content url="https://biz-file.com/c/2610/825244-1200x800.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/825244-1200x800.jpg?5" length="213706" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2610/825244.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272570</guid>
	<pubDate>Thu, 15 Oct 2026 08:06:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Ampath says data breach claims of “80 million patient records” are overstated</title>
	<link>https://www.bizcommunity.com/article/ampath-says-data-breach-claims-of-80-million-patient-records-are-overstated-303808a</link>
	<description>Pathology service provider Ampath has confirmed a “cybersecurity incident” that compromised certain personal demographic and related administrative information. However, it has cautioned South Africans against claims made by the threat actor ByteToBreach, which MyBroadband reports has claimed responsibility for the breach.</description>
	<media:content url="https://biz-file.com/c/2610/825176-1200x842.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/825176-1200x842.jpg?5" length="338555" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2610/825176.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272553</guid>
	<pubDate>Wed, 14 Oct 2026 13:57:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Bitter pill to swallow: Medicine prices in the private health sector increase</title>
	<link>https://www.bizcommunity.com/article/bitter-pill-to-swallow-medicine-prices-in-private-sector-increase-292217a</link>
	<description>The Department of Health has announced a 2.88% increase in the single exit price (SEP) for all registered medicines listed in the national database, effective from 1 October 2026.</description>
	<media:content url="https://biz-file.com/c/2610/823901-1200x800.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2610/823901-1200x800.jpg?5" length="361644" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2610/823901.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272170</guid>
	<pubDate>Thu, 01 Oct 2026 08:32:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>Obiflex is bringing buy-now-pay-later to GLP-1 medicines in SA</title>
	<link>https://www.bizcommunity.com/article/obiflex-is-bringing-buy-now-pay-later-to-glp-1-medicines-in-sa-292517a</link>
	<description>The South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC) recently cracked down on compounded GLP-1 weight-loss medicines, making it harder for some cash-strapped South Africans to access registered, doctor-prescribed alternatives to Wegovy, Ozempic, and Mounjaro. A new doctor-led health management programme now aims to offer those medicines through a buy-now-pay-later payment structure.</description>
	<media:content url="https://biz-file.com/c/2609/823633-1200x1600.jpg?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2609/823633-1200x1600.jpg?5" length="824663" type="image/jpeg" />
	<media:thumbnail url="https://biz-file.com/c/2609/823633.jpg?5" width="240" height="135" />
	<guid isPermaLink="false">1-272070</guid>
	<pubDate>Tue, 29 Sep 2026 09:06:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>The race for relief: Competition within South Africa’s cough, cold and flu market</title>
	<link>https://www.bizcommunity.com/article/the-race-for-relief-competition-within-south-africas-cough-cold-and-flu-market-414729a</link>
	<description>South Africa’s cough, cold and flu market is characterised by strong growth, seasonal demand and continued activity from established brands competing for consumer attention. While the flu season remains an important period for campaigns and promotions, competition is also playing out through product development, consumer engagement and healthcare professional initiatives, as manufacturers seek to maintain the relevance of their brands throughout the year.</description>
	<media:content url="https://biz-file.com/c/2609/823480.png?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2609/823480.png?5" length="102924" type="image/png" />
	<media:thumbnail url="https://biz-file.com/c/2609/823480.png?5" width="240" height="135" />
	<guid isPermaLink="false">1-272045</guid>
	<pubDate>Fri, 25 Sep 2026 16:01:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
<item>
	<title>“Ozempic face” and the GLP-1 boom are changing the face of beauty</title>
	<link>https://www.bizcommunity.com/article/ozempic-face-and-the-glp-1-boom-are-changing-the-face-of-beauty-853633a</link>
	<description>As pharmaceutical companies clean up the GLP-1 aisle, the rise of “Ozempic face”—the loss of facial volume from rapid weight loss—is creating an opportunity for beauty brands.</description>
	<media:content url="https://biz-file.com/c/2609/823282.png?5" medium="image" width="1200" height="624" />
	<enclosure url="https://biz-file.com/c/2609/823282.png?5" length="175320" type="image/png" />
	<media:thumbnail url="https://biz-file.com/c/2609/823282.png?5" width="240" height="135" />
	<guid isPermaLink="false">1-271989</guid>
	<pubDate>Fri, 25 Sep 2026 08:00:00 +0200</pubDate>
	<source url="https://www.bizcommunity.com/rss/196/398.html">Bizcommunity Pharmaceuticals South Africa</source>
</item>
</channel>
</rss>